Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine 11, 1197 - 1204 (2005)
Published online: 23 October 2005; | doi:10.1038/nm1313

Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling

Kengo F Kusano1, Roberto Pola2, Toshinori Murayama1, Cynthia Curry1, Atsuhiko Kawamoto1, Atsushi Iwakura1, Satoshi Shintani1, Masaaki Ii1, Jun Asai1, Tengiz Tkebuchava1, Tina Thorne1, Hideya Takenaka1, Ryuichi Aikawa1, David Goukassian1, Patrick von Samson1, Hiromichi Hamada1, Young-sup Yoon1, Marcy Silver1, Elizabeth Eaton1, Hong Ma1, Lindsay Heyd1, Marianne Kearney1, William Munger3, Jeffery A Porter3, Raj Kishore1 & Douglas W Losordo1

1  Division of Cardiovascular Research, St. Elizabeth Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA.

2  Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy.

3  Curis, Inc., 8 Moulton Street, Cambridge, Massachusetts 02138, USA.

Correspondence should be addressed to Douglas W Losordo douglas.losordo@tufts.edu

Sonic hedgehog (Shh) is a crucial regulator of organ development during embryogenesis. We investigated whether intramyocardial gene transfer of naked DNA encoding human Shh (phShh) could promote a favorable effect on recovery from acute and chronic myocardial ischemia in adult animals, not only by promoting neovascularization, but by broader effects, consistent with the role of this morphogen in embryogenesis. After Shh gene transfer, the hedgehog pathway was upregulated in mammalian fibroblasts and cardiomyocytes. This resulted in preservation of left ventricular function in both acute and chronic myocardial ischemia by enhanced neovascularization, and reduced fibrosis and cardiac apoptosis. Shh gene transfer also enhanced the contribution of bone marrow–derived endothelial progenitor cells to myocardial neovascularization. These data suggest that Shh gene therapy may have considerable therapeutic potential in individuals with acute and chronic myocardial ischemia by triggering expression of multiple trophic factors and engendering tissue repair in the adult heart.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 21 articles citing this articleCrossRef lists 21 articles citing this article
Save this linkSave this link

Open Innovation Challenges

naturejobs

Competing financial interests
Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2005 Nature Publishing Group | Privacy policy